ScreenerHero
MIRMedMira Inc.
TSXV · CA · Healthcare · Biotechnology · medmira.com
0.0600CAD0.00%Mkt Cap: 30.66M $P/E: —

MedMira Inc., a biotechnology company, researches, develops, manufactures, and sells rapid diagnostics and technology platforms in North America, Europe, and internationally. The company offers Reveal HIV, a test that de…

Industry Peers

Biotechnology
Screen all
VRTX
Vertex Pharmaceuticals Incorporated
$139.84BUSDP/E 32.2
REGN
Regeneron Pharmaceuticals, Inc.
$85.11BUSDP/E 20.4
MRNA
Moderna, Inc.
$69.62BUSD
ARGX
ARGENX SE
$60.19BUSDP/E 39.1
UCB
UCB SA
$45.16BUSDP/E 19.2
RVMD
Revolution Medicines, Inc.
$46.01BUSD
ONC
BeOne Medicines AG
$41.76BUSDP/E 66.2
RPRX
Royalty Pharma Plc Class A
$35.67BUSDP/E 33.2
ALNY
Alnylam Pharmaceuticals, Inc.
$32.46BUSDP/E 42.3
INSM
Insmed Incorporated
$28.53BUSD
22UA
BioNTech SE
$26.14BUSD
INCY
Incyte Corporation
$25.79BUSDP/E 16.2
GMAB
Genmab A/S
$20.83BUSDP/E 26.3
GMAB
Genmab A/S
$19.17BUSDP/E 26.2
ASND
Ascendis Pharma A/S
$17.03BUSDP/E 20.0
BBIO
BridgeBio Pharma, Inc.
$16.41BUSD
EXEL
Exelixis, Inc.
$13.48BUSDP/E 17.1
BMRN
BioMarin Pharmaceutical Inc.
$13.42BUSDP/E 187.4
CORT
Corcept Therapeutics Incorporated
$12.87BUSDP/E 264.5
ARWR
Arrowhead Pharmaceuticals, Inc.
$12.59BUSD

Key Statistics

Company
Market Cap30.66M $
Enterprise Value—
Revenue (TTM)269.87K $
Gross Profit125.88K $
Net Income (TTM)-3.29M $
Revenue/Share0.0007 USD
Last Price0.0600 CAD
Fiscal Year EndJul 2025
MR QuarterApr 2026
Employees—
CountryCA
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)—
PEG—
EV/EBITDA—
EV/Revenue—
P/S113.62
P/B-1.71
EPS (TTM)0.00
EPS (Forward)—
52W Range
0.050017% of range0.1100
52W High0.1100 CAD
52W Low0.0500 CAD
Profitability
Gross Margin71.87%
Oper. Margin-109.79%
EBITDA Margin0.00%
Profit Margin-1881.18%
ROE20.05%
ROA-122.89%
Growth
Revenue Growth308.00%
Earnings Growth—
Cash Flow & Leverage
Operating CF-2.29M $
CapEx (TTM)5.44K $
FCF Margin-32.13%
FCF Yield-0.28%
Net Debt—
Net Debt/EBITDA—
Balance Sheet
Debt/Equity-0.47
Current Ratio0.06
Quick Ratio0.05
Book Value/Sh-0.0350 CAD
Cash/Share—
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 CAD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.701.73M
Float209.72M
Insiders65.54%
Institutions0.00%
Short Interest
Short Ratio0.1d
Short % Out.0.00%
Shares Short538
Short (prev mo.)721
Technical
SMA 500.0670 (-10.4%)
SMA 2000.0677 (-11.3%)
Beta0.76
S&P 52W Chg18.16%
Avg Vol (30d)48.30K
Avg Vol (10d)56.68K
Technical Indicators
RSI (14)44.9
MACD-0.0011
MACD Signal-0.0007
MACD Hist.-0.0004
BB Upper0.0716 CAD
BB Middle0.0641 CAD
BB Lower0.0566 CAD
BB Width23.34%
ATR (14)0.0035 CAD
Vol Ratio (20d)0.28x